% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • settoplunge settoplunge May 28, 2013 6:06 PM Flag

    No New Trials

    According to JN:
    "The company is preparing a response to the issues raised by the FDA using existing data from the development program. We do not know when that response will be submitted. Management will also be requesting a meeting with the FDA to discuss response and clarification on the regulatory path forward for Probuphine. The company notes working closely with regulatory counsel and a team of expert advisers to address the FDA’s response to the Probuphine NDA. We do not know when that meeting will take place."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.07+1.51(+21.36%)May 26 2:49 PMEDT